Cancer Incidence and Mortality for Seneca County, 2015-2019

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 242.0 523.7 493.3-555.6 129.4 574.5 529.6-622.3 112.6 489.2 446.8-534.8 80.6 166.3 150.0-184.1 41.8 184.8 160.0-212.7 38.8 154.4 132.6-179.3
Oral cavity and pharynx 6.6 14.3 9.6-20.6 4.8 20.3 12.7-31.1 1.8 8.2 3.6-16.6 1.0 1.9 0.6-4.9 1.0 4.0 1.3-10.3 0.0 0.0 0.0-4.8
Esophagus 3.4 6.8 3.9-11.2 3.0 12.6 7.0-21.4 0.4 1.5 0.2-6.9 4.6 8.7 5.5-13.5 4.2 16.7 10.2-26.4 0.4 1.5 0.2-6.9
Stomach 4.2 8.8 5.3-13.8 3.4 14.3 8.3-23.6 0.8 4.4 1.1-11.9 1.0 1.8 0.6-4.8 0.8 3.4 0.9-9.4 0.2 0.6 0.0-5.6
Colorectal 16.6 36.7 28.9-46.1 9.2 41.0 29.6-55.6 7.4 33.6 23.1-47.7 5.4 11.3 7.3-16.8 3.2 13.8 7.7-23.0 2.2 9.5 4.4-18.1
Colon excluding rectum 12.2 26.6 20.1-34.7 6.4 28.4 19.2-40.9 5.8 25.7 16.8-38.0 4.4 9.3 5.7-14.6 2.6 11.1 5.8-19.6 1.8 8.1 3.5-16.6
Rectum & rectosigmoid 4.4 10.1 6.1-15.8 2.8 12.6 6.7-21.9 1.6 8.0 3.1-16.9 1.0 1.9 0.6-5.0 0.6 2.7 0.5-8.6 0.4 1.4 0.2-6.6
Liver / intrahepatic bile duct 3.4 6.6 3.7-11.1 1.8 6.9 3.1-14.0 1.6 6.7 2.5-14.7 3.0 5.6 3.1-9.6 2.0 8.2 3.9-15.9 1.0 3.5 1.1-9.6
Pancreas 7.6 15.2 10.6-21.3 4.4 19.0 11.7-29.5 3.2 11.6 6.6-19.8 5.8 11.7 7.7-17.3 2.4 10.6 5.4-19.1 3.4 13.1 7.3-22.4
Larynx 1.0 2.3 0.7-5.8 0.8 4.0 1.0-10.6 0.2 0.7 0.0-5.9 0.8 1.6 0.4-4.6 0.4 1.4 0.2-6.4 0.4 1.7 0.2-7.3
Lung and bronchus 36.4 74.9 64.1-87.1 16.6 71.4 56.6-89.3 19.8 79.3 63.8-97.9 23.6 48.0 39.5-58.0 10.2 43.6 32.1-58.2 13.4 52.0 40.0-67.0
Melanoma of the skin 11.8 27.4 20.5-36.0 7.8 37.2 26.0-51.7 4.0 18.8 11.0-30.3 1.4 3.1 1.2-6.9 0.2 0.7 0.0-5.4 1.2 5.5 1.8-13.1
Female breast             28.6 127.3 105.7-152.2             4.0 17.2 10.1-27.7
Cervix uteri             1.6 9.2 3.8-18.6             0.8 3.6 0.9-10.2
Corpus uterus and NOS             10.2 42.6 31.1-57.3             0.6 2.2 0.5-7.9
Ovary             2.4 10.6 5.2-19.6             1.8 7.1 3.2-14.5
Prostate       30.2 122.0 102.9-144.0             2.4 11.8 6.1-20.9      
Testis       1.8 10.4 4.6-20.0             0.0 0.0 0.0-4.3      
Urinary bladder (incl. in situ) 10.0 19.3 14.2-25.9 7.2 30.5 21.1-42.9 2.8 9.4 5.1-17.0 1.0 1.9 0.6-5.0 0.6 3.1 0.6-9.3 0.4 1.4 0.2-6.6
Kidney and renal pelvis 8.8 21.6 15.4-29.5 6.4 30.2 20.3-43.4 2.4 13.0 6.2-23.8 1.4 2.7 1.1-6.1 1.0 3.4 1.1-9.0 0.4 2.1 0.2-8.1
Brain and other central nervous system 3.4 8.4 4.8-13.9 1.6 8.1 3.4-16.4 1.8 8.9 3.7-18.1 1.8 3.3 1.5-6.8 1.0 3.5 1.1-9.3 0.8 3.3 0.8-9.8
Thyroid 5.0 15.8 10.0-23.6 1.2 7.8 2.8-17.0 3.8 24.6 14.3-39.2 0.0 0.0 0.0-2.3 0.0 0.0 0.0-4.3 0.0 0.0 0.0-4.8
Hodgkin lymphoma 2.6 6.6 3.4-11.7 1.6 8.4 3.5-17.0 1.0 4.9 1.5-12.3 0.4 1.1 0.1-4.1 0.0 0.0 0.0-4.3 0.4 2.2 0.2-8.6
Non-Hodgkin lymphomas 9.6 21.1 15.4-28.5 6.2 29.5 19.8-42.5 3.4 13.3 7.5-22.3 3.4 7.1 4.1-11.8 2.0 9.6 4.5-18.1 1.4 5.0 2.0-11.6
Myeloma 1.8 3.7 1.7-7.5 1.4 6.7 2.6-14.2 0.4 1.5 0.2-6.9 1.0 2.1 0.7-5.4 0.6 2.9 0.6-8.9 0.4 1.7 0.2-7.3
Leukemias 8.6 19.7 14.1-27.1 6.0 29.9 19.9-43.3 2.6 11.0 5.7-19.8 3.8 8.5 5.0-13.7 3.2 16.5 9.4-27.1 0.6 2.3 0.5-8.1

Notes

  • Incidence data are provisional, November 2021.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.